Abstract:Reduced vascular perfusion due to aging, ischemia, or injury impedes healing and tissue function in conditions like skin ulcers and myocardial infarction, motivating development of therapies to restore vasculature locally in target tissues. We hypothesize that specific combinations of signaling molecules stimulate angiogenesis and vascular remodeling in the local tissue environment to increase perfused vessel density. Using a vascular tissue engineering approach with a fractional factorial design of experiments (DOE), we evaluated in vivo angiogenesis of combinations of ten growth factors, cytokines and/or enzymes including VEGF, bFGF, Shh, PDGF, IGF-1, EGF, TGF-β1, Ang-1, MCP-1 and MMP-9 in a subcutaneous gel plug assay in the WT immune competent rat. Our initial assessment with Matrigel identified 5 factors that maximized CD31+ vessel lumen density and aSMA+ encoated vessels at 7 days, warranting further evaluation. We developed a fully defined biomaterial system with covalently bound heparin to alginate mixed with collagen type 1 as an injectable gel. This defined biomaterial prolonged protein release up to 14 days in vitro versus Matrigel and unmodified alginate (2-4 days). The defined biomaterial was used for a second round DOE to deliver high (2 μg) and low (0.5 μg) doses of VEGF, bFGF, Shh, PDGF, and/or IGF-1. The defined biomaterial alone enhanced average lumen diameter 15-fold and endothelial cell infiltration 12-fold versus Matrigel. Perfused lumen density increased 16-fold with high Shh; aSMA-positive lumen wall area increased 4-fold with high VEGF, PDGF, and IGF-1; perfused vessel size increased 3-fold with high VEGF, bFGF, and Shh; and endothelial cell recruitment increased 2-fold with high IGF-1 relative to unloaded controls after 7 days in vivo. Empirical testing of 2- to 5-factor combinations showed that cocktail potency required initiation of angiogenic sprouting by VEGF or bFGF and vascularization responses were strongest in the presence of Shh and IGF-1. In conclusion, we identified sets of highly potent cocktails and leveraged controlled release from a defined biomaterial as a tailored revascularization therapy for local angiogenesis, vascular remodeling, and tissue regeneration.

Bioactive Additives from Mouse Dorsal Dermis of Mice for Enhanced Vascularization in 3D Bioprinting

Patterned Vascularization in a Directional Ice‐templated Scaffold of Decellularized Matrix

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Enhancement of Viability of Fat Grafts in Nude Mice by Endothelial Progenitor Cells

Dual Gene-Activated Dermal Scaffolds Regulate Angiogenesis and Wound Healing by Mediating the Coexpression of VEGF and Angiopoietin-1

Thermo-sensitive Sacrificial Microsphere-based Bioink for Centimeter-scale Tissue with Angiogenesis

Cell-modified Bioprinted Microspheres for Vascular Regeneration

Vascular Derived ECM Improves Therapeutic Index of BMP-2 and Drives Vascularized Bone Regeneration.

3D-Printed Proangiogenic Patches of Photo-Crosslinked Gelatin and Polyurethane Hydrogels Laden with Vascular Cells for Treating Vascular Ischemic Diseases

Nanomaterials for the Delivery of Bioactive Factors to Enhance Angiogenesis of Dermal Substitutes During Wound Healing

A potential dermal substitute using decellularized dermis extracellular matrix derived bio-ink

Use of Amniotic Microparticles Coated with Fibroblasts Overexpressing SDF-1a to Create an Environment Conducive to Neovascularization for Repair of Full-Thickness Skin Defects

A heparin-functionalized bioink with sustained delivery of vascular endothelial growth factor for 3D bioprinting of prevascularized dermal constructs

Three-Dimensional Bioprinting of Decellularized Extracellular Matrix-Based Bioinks for Tissue Engineering

Recent Advances in Decellularized Matrix-Derived Materials for Bioink and 3D Bioprinting

Freestanding vascular scaffolds engineered by direct 3D printing with Gt-Alg-MMT bioinks

3D bioprinting of mechanically tuned bioinks derived from cardiac decellularized extracellular matrix

Directed differential behaviors of multipotent adult stem cells from decellularized tissue/organ extracellular matrix bioinks

Abstract P1129: Directing Revascularization In Vivo With Local Controlled Release Of An Optimized Angiogenic Growth Factor Cocktail

3D printed GelMA/carboxymethyl chitosan composite scaffolds for vasculogenesis

In Vitro Angiogenesis of 3D Tissue Engineered Adipose Tissue